Compare Roivant Sciences Ltd. Common Shares (ROIV) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Roivant Sciences Ltd. Common Shares vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Roivant Sciences Ltd. Common Shares trades at $34.27 (market cap $24.72B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.61 (market cap $25.27B). The key difference: Roivant Sciences Ltd. Common Shares and Royalty Pharma plc Class A Ordinary Shares are close in size by market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 0 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| ROIV | RPRX | |
|---|---|---|
Market Cap | $24.72B | $25.27B |
Volume | 6,279,442 | 3,671,183 |
Sector | Health | Health |
52-Week High | $41.81 | $63.96 |
52-Week Low | $16.04 | $35.44 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $20.99B | $32.50B |
Dividend Yield | — | 1.66% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
